Astrana Health Inc(ASTH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 5:37 PM ET (Korea 9/12 06:37)
Full metrics table
| Index | RUT | P/E | 46.35 | EPS (ttm) | 0.82 | Insider Own | 20.89% | Shs Outstand | 49.2M | Perf Week | 0.4% |
| Market Cap | 1.88B | Forward P/E | 19.53 | EPS next Y | 39.65% | Insider Trans | - | Shs Float | 39.2M | Perf Month | 6.12% |
| Enterprise Value | 2.23B | PEG | 0.25 | EPS next Q | 0.45 | Inst Own | 65.18% | Short Float | 8.36% | Perf Quarter | -4.69% |
| Income | 0.04B | P/S | 0.49 | EPS this Y | 202.76% | Inst Trans | 5.43% | Short Ratio | 5.76 | Perf Half Y | 63.35% |
| Sales | 3.84B | P/B | 2.25 | EPS next 5Y | 77.5% | ROA | 2.18% | Short Interest | 3.28M | Perf YTD | 53.08% |
| Book/sh | 16.87 | P/C | 4.68 | EPS past 3/5Y | -22.81% -14.74% | ROE | 5.08% | 52W High | -26.4% ($51.60) | Perf Year | 25.02% |
| Cash/sh | 8.11 | P/FCF | 19.96 | Sales past 3/5Y | 40.62% 35.87% | ROIC | 2.32% | 52W Low | 110.07% ($18.08) | Perf 3Y | 14.4% |
| Dividend Est. | - | EV/EBITDA | 13.64 | EPS Y/Y TTM | 58.36% | Gross Margin | 8.82% | Volatility(W/M) | 4.26% 4.32% | Perf 5Y | -59.97% |
| Dividend TTM | - | EV/Sales | 0.58 | Sales Y/Y TTM | 58.91% | Oper. Margin | 2.61% | ATR (14) | 1.68 | Perf 10Y | 826.34% |
| Dividend Ex-Date | - | Quick Ratio | 1.23 | EPS Q/Q | 108.14% | Profit Margin | 1.05% | RSI (14) | 46.99 | Recom | 1.4 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.23 | Sales Q/Q | 48.52% | SMA20 | -1.56% ($38.58) | Beta | 1.02 | Target Price | $51.5 |
| Payout | - | Debt/Eq | 1.18 | Earnings | 2026/8/6 | SMA50 | -5.5% ($40.19) | Rel Volume | 0.34 | Prev Close | $38.03 |
| Employees | 3000 | LT Debt/Eq | 1.1 | EPS/Sales Surpr. | 19.12% -0.99% | SMA200 | 19.83% ($31.69) | Avg Volume(3M) | 0.57M | Price | $37.98 |
| IPO | 2006/10/23 | Option/Short | Yes/Yes | Trades | 5777 | Volume | 191,699 | Change | -0.13% |
Company
ASTH is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🏥 A US integrated healthcare platform company providing value-based care. It operates a value-based care model that combines its physician network with risk-bearing medical care, integrating patient treatment and cost management, and leverages its technology platform to enhance healthcare efficiency. It has established itself as a value-based care platform operator that combines its physician network, managed care, and technology.
Over the past 1 year, roughly in the middle
26% below its 1-year high.
ASTH earns at a steady pace
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +202.8% this year.
Tap to view numbers
The price looks about right
Trading at 46.4 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +14.4% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 65.2%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
XHS 0.02%
HEAL 0.01%
HYP 0.01%
RZV 0.01%
PSCH 0.01%It ranks #4 in the industry
Based on market cap of $2B.
ASTH $2B PER 46.4
HCA $92B PER 14.3
THC $21B PER 10.2
EHC $12B PER 19.8
FAQ
What kind of company is ASTH?
ASTH belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of ASTH?
The market cap of ASTH is approximately $1.9B, ranking 2,153 within its sector.
What is the P/E ratio of ASTH?
ASTH has a P/E ratio of approximately 46.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ASTH?
ASTH has recorded a 52-week high of $51.60 and a low of $18.08.
